rs104894459
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_001354768.3(NRL):c.148T>C(p.Ser50Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S50T) has been classified as Pathogenic.
Frequency
Consequence
NM_001354768.3 missense
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 27Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- enhanced S-cone syndromeInheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NRL | NM_001354768.3 | c.148T>C | p.Ser50Pro | missense_variant | Exon 2 of 3 | ENST00000561028.6 | NP_001341697.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NRL | ENST00000561028.6 | c.148T>C | p.Ser50Pro | missense_variant | Exon 2 of 3 | 2 | NM_001354768.3 | ENSP00000454062.2 | ||
| NRL | ENST00000396997.1 | c.148T>C | p.Ser50Pro | missense_variant | Exon 3 of 4 | 1 | ENSP00000380193.1 | |||
| NRL | ENST00000397002.6 | c.148T>C | p.Ser50Pro | missense_variant | Exon 2 of 3 | 1 | ENSP00000380197.2 | |||
| NRL | ENST00000558280.1 | c.148T>C | p.Ser50Pro | missense_variant | Exon 3 of 3 | 5 | ENSP00000454180.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Ser50 amino acid residue in NRL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11879142, 17335001, 33691693). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects NRL function (PMID: 17335001). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This missense change has been observed in individuals with autosomal dominant retinitis pigmentosa (PMID: 11879142; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 50 of the NRL protein (p.Ser50Pro). -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at